Ignite Creation Date:
2024-05-05 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00711386
Status:
COMPLETED
Last Update Posted:
2017-08-03
First Post:
2008-07-03
Brief Title:
GSK706769 Repeat Dose Study
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Double-Blind Randomized Placebo-Controlled Repeat Dose Escalation Study to Investigate the Safety Tolerability and Pharmacokinetics of GSK706769 in Healthy Male and Female Subjects
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine safety tolerability and Pharmacokinetics of GSK706769
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None